MSB 2.70% 95.0¢ mesoblast limited

Ann: Trading Halt, page-86

  1. 30,340 Posts.
    lightbulb Created with Sketch. 1837
    The potency assay is a sudden fixation of the FDA and a side-issue and resolved after some careful lab work.
    All MSB has had to do is resolve the precision inconsistencies, and then do the batch testing this is process not substance.

    An obvious but key point: It's not about efficacy of remestemcel-L is it?

    (whytee is always getting this wrong IDK what to do about her misconceptions whether they'r deliberate or just from limited intelligence, but I guess it's irrelevant. but with you it's fear-based and that's different, she's simply feeding the fear).

    SI patiently explained the difference at the AGM and this has been spelled out multiple times in here.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.